Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04302428 · ClinicalTrials.gov registry record
Zinc Status and Growth in Cystic Fibrosis
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 35
- Enrollment target
NCT04302428 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 35 participants.
The verdict
NCT04302428 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to improve the understanding of the relationship of zinc status and growth in infants and young children who were diagnosed with cystic fibrosis via newborn screening.
Interventions
- BIOLOGICAL Serum Zn
- BIOLOGICAL Red Blood Cell Zn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2019-08-29 |
| Est. Completion | 2021-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04302428
The ClinicalTrials.gov registry entry for NCT04302428 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Serum Zn is the first listed.
NCT04302428 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04302428 about?
NCT04302428 is a clinical study titled "Zinc Status and Growth in Cystic Fibrosis". The purpose of this study is to improve the understanding of the relationship of zinc status and growth in infants and young children who were diagnosed with cystic fibrosis via newborn screening.
What is the current status of trial NCT04302428?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2019-08-29. Estimated completion is 2021-03-30.
What interventions are being tested in trial NCT04302428?
The interventions under investigation include: Serum Zn (BIOLOGICAL), Red Blood Cell Zn (BIOLOGICAL).
Who is sponsoring clinical trial NCT04302428?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.